IM Cannabis consolidates shares for renewed Nasdaq trading
The company adjusts its share structure to meet exchange listing requirements while maintaining its existing ticker symbol and operational focus in Israel and Germany.
See the latest news and media coverage for IMC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis company
imcannabis.comLast updated
In short: IMC agreed to sell its European assets and consolidated shares for Nasdaq compliance while securing convertible note financing.
The company adjusts its share structure to meet exchange listing requirements while maintaining its existing ticker symbol and operational focus in Israel and Germany.
The company executes a 30-for-1 share consolidation to raise its stock price above the $1.00 minimum bid price requirement by late August 2026.
Revenue fell to $7.6 million in Q2 and $16.3 million in H1, with net losses of $4.4 million and $6.9 million.
The note bears 8% interest and is convertible into common shares, with proceeds for general corporate purposes.
30-for-1 reverse split is expected to cut IM Cannabis shares from 18.1M to about 604K as it targets Nasdaq’s $1 bid rule ahead of an...
IM Cannabis (NASDAQ:IMCC) has entered into a definitive agreement to sell IMC Holdings and its European-focused assets to Slil.com Holding, a transaction management expects to...
IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it...
"Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. "Achieving net profitability and an 87% improvement in...
Track IMC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IMC and other trending companies.